Asia Medical Devices Reports - Espicom

Independent forecasts, business opportunities
and competitive intelligence covering 16 different
Asian countries
Espicom’s 16 Medical Devices Reports provide industry professionals and strategists with
independent 5-year market forecasts for the medical market and healthcare systems,
together with demographic forecasts and healthcare expenditure projects on the medical
devices industry in each Asian market.
BENCHMARK
YOUR BUSINESS DEVELOPMENT PLAN
AGAINST ESPICOM’S FORECASTS
Espicom’s Medical Devices forecasts
cover more than 60 countries using a
sophisticated forecasting model that takes
into account macroeconomic and industry
factors, allowing analyst intervention.
Use Espicom’s standardised data to gain
a better understanding of key market
performance in each country.
UNDERSTAND
AND QUANTIFY OPERATIONAL AND
MARKET RISKS TO INVESTMENT
The reports look at the critical issues and
drivers which are shaping the Medical
Devices market. The continually updated
forecasts, reflecting current and anticipated
market conditions can be used to evaluate
the operating environment for medical
device companies regarding both domestic
production and trade.
BMI’S CUSTOMERS INCLUDE:
Abbott Laboratories
Alcon Laboratories
AstraZeneca
Baxter Healthcare
Boehringer Ingelheim GmbH
Filchem Australia Pty Limited
EXPLOIT
EMERGING MARKET TRENDS TO
SUPPORT YOUR BUSINESS PLANS
Our analysts identify the key demographic,
disease, regulatory and economic trends
that will shape a market’s development
over the coming years. The impact of
country, regional and global dynamics are
evaluated, as are the broader economic,
demographic and political drivers. The
result is a unique evaluation of all major
issues likely to support, strengthen or
disrupt company-specific business plans,
allowing you to shape and support your
business plans accordingly, using our
reliable business data.
ANALYSE
THE INVESTMENT POTENTIAL OF THE
MEDICAL DEVICE MARKET
The reports provide you with individual
and highly detailed analysis of the factors
driving or impeding growth together with
the key regulatory, political, economic
and corporate developments. These can
include the global economy, healthcare
expansions, government budgets and tax
legislation and disease trends.
GlaxoSmithKline plc
McKinsey & Company
Novartis Pharmaceuticals
Pfizer Ltd
Roche Thailand Ltd
Sanofi-aventis
KEY BENEFITS OF
EACH REPORT
CALL NOW to order on +44 (0)1243 756027 or email direct_sales@espicom.com
Market Opportunities – Scope
opportunities for new investment or
sales growth via our proprietary market
forecasts, which cover all major industry,
economic and demographic indicators.
Risk Management – Identify and
quantify operational, market and countryspecific
risks to your activities.
Trend Analysis and Forecasts –
Evaluate the commercial potential
of regulatory and reimbursement
developments, investment dynamics,
new research and broader demographic
and disease trends, as well as the
impact of global/regional dynamics in
your market and domestic demand.
Regulatory Updates – Use our
extensively researched coverage of
regulatory developments via over
1,200 primary source information
points in regulatory authorities, health
organisations, and government agencies
to acquire information not readily
available in English anywhere else.